Long COVID

A new study suggests that COVID-19 may worsen existing health problems over the long term, adding to the growing body of research on the virus's lasting effects. The finding was shared with a sardonic tone, framed as an obvious conclusion, but reflects ongoing concern about long COVID and its impact on people with pre-existing conditions.

A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to concerns about the lasting effects of infection. The finding points to a broader long-term health burden beyond long COVID itself, with implications for patients managing chronic conditions and for health systems assessing ongoing care needs.

A new study indicates healthcare workers are battling persistent long COVID symptoms, with many continuing to experience fatigue, brain fog and other lasting effects well after infection. The findings highlight the ongoing toll of the pandemic on medical staff, raising concerns about workforce shortages and the need for better support and treatment for affected clinicians.

A new cross-sectional study published in Nature examines the risk factors associated with post-COVID-19 symptoms in patients with asthma and chronic obstructive pulmonary disease. The research aims to identify which characteristics make people with these chronic lung conditions more likely to experience lingering symptoms after infection, a question of ongoing concern for respiratory clinicians.

Ontario is rolling out Covid and flu vaccinations beginning September 28 for priority groups, including hospital patients and staff, people aged 65 and older, and residents and staff of long-term care homes, retirement homes and similar settings. The early access is aimed at protecting the most vulnerable before the wider respiratory illness season, with broader eligibility for the general public expected to follow later.

Researchers at WashU Medicine report that influenza, like COVID-19, can produce lasting symptoms — a 'long flu' that lingers for months after infection. Coverage highlights ways to lower the risk, including annual flu vaccination and seeking early antiviral treatment. The findings are drawing attention as flu seasons intensify and awareness of post-viral illness grows.

Years after the height of the pandemic, many Minnesotans continue to live with long COVID, the lingering illness that can follow even mild infections. Minnesota Public Radio reports that sufferers across the state are still dealing with symptoms such as fatigue, brain fog and breathing problems, keeping attention on the condition among patients, doctors and health officials.

After weeks of uncertainty and delays, the federal government has begun distributing COVID-19 vaccines for children from low-income families. The move ends a limbo that had left many families and clinics waiting for doses, and it raises questions about what caused the holdup and whether supply will now reach providers reliably.

Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.